Issue 61, 2019

A potent free fatty acid receptor 1 agonist with a glucose-dependent antihyperglycemic effect

Abstract

We present a novel free fatty acid receptor 1 (FFA1) agonist, named PAFA, with a strong agonist potency (EC50 = 6.04 nM) and good serum stability. PAFA significantly stimulates insulin secretion in INS-1 cells in a glucose-dependent manner and exhibits high antihyperglycemic effects in db/db mice without adverse effects.

Graphical abstract: A potent free fatty acid receptor 1 agonist with a glucose-dependent antihyperglycemic effect

Supplementary files

Article information

Article type
Communication
Submitted
25 May 2019
Accepted
03 Jul 2019
First published
03 Jul 2019

Chem. Commun., 2019,55, 8975-8978

A potent free fatty acid receptor 1 agonist with a glucose-dependent antihyperglycemic effect

X. Wang, Y. Xu, S. Feng, X. Huang, X. Meng, J. Chen, L. Guo, J. Ge, J. Zhang, J. Chen, L. Cheng, K. Gu, Y. Zhang, Q. Jiang and X. Ning, Chem. Commun., 2019, 55, 8975 DOI: 10.1039/C9CC04040D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements